Trademark: 79359897
Status Date
Wednesday, March 20, 2024
Filing Date
Friday, November 18, 2022
Published for Opposition
Tuesday, April 23, 2024
5 Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal stem cells for medical and veterinary purposes; preparations of microorganisms for medical and veterinary purposes; viral vectors being tissue cultures for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids for medical and veterinary use being biological preparations for the treatment of cardiovascular, degenerative, dermatological, endocrine, gastrointestinal, genetic, gynaecological, neurological, infectious, immunological, metabolic, oncological, ophthalmic, respiratory and urological disorders and diseases
1 Chemical and biological preparations for use in science and industry; nucleic acids for laboratory use; nucleic recombinant acids for laboratory use, synthetic deoxyribonucleic acids for laboratory use; chemical and biological reagents for non-medical and non-veterinary purposes; chemical and biological reagents for scientific and research purposes; human and animal stem cells for non-medical and non-veterinary purposes; microorganisms for non-medical purposes being cultures of microorganisms other than for medical and veterinary use; human and animal stem cells for scientific and research purposes; cultures of microorganisms for scientific and research purposes; viral vectors being chemicals and biological preparations for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids being chemicals and biological preparations for scientific and research purposes
42 Product design and development services relating to the creation and alteration of chemical and biological reagents; new product design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; new product design services relating to the creation and alteration of recombinant viruses; new product design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; scientific research, product development and bioengineering services relating to lentiviruses; drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof being drug discovery services; design services relating to the creation and alteration of viral vectors being drug discovery services; information and advice relating to all the aforesaid services
Apr 10, 2024
Notification Of Possible Opposition Sent To Ib
Apr 10, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 3, 2024
Notification Of Notice Of Publication E-Mailed
Mar 20, 2024
Approved For Pub - Principal Register
Mar 19, 2024
Teas/Email Correspondence Entered
Mar 19, 2024
Correspondence Received In Law Office
Mar 19, 2024
Teas Response To Office Action Received
Oct 11, 2023
Refusal Processed By Ib
Sep 20, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Sep 20, 2023
Refusal Processed By Mpu
Sep 1, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Aug 31, 2023
Non-Final Action Written
Aug 31, 2023
Assigned To Examiner
Jan 13, 2023
Application Filing Receipt Mailed
Jan 9, 2023
New Application Office Supplied Data Entered
Jan 6, 2023
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
